Clinical experience has shown that the AATD phenotype is only partially attributed to the genotype, i.e., pathogenic variants of SERPINA1, and this disparity is not fully explained by smoking or environmental exposure. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.